By understanding the potential of your molecules, we can frame your options and make decision making the biggest differentiating factor in your products’ success. We take a forward-looking approach, anticipating the future and helping you prepare for what’s ahead.
An asset or brand requires ongoing decision support from early Phase II through to the end of its life cycle. Biopharmaceutical companies are continuously required to make decisions based on current conditions and an uncertain future; we provide clarity on both. We focus not only on those events clients can plan for, but also predict and respond to those they cannot.
Functioning alongside R&D and commercial, medical is one of the three strategic pillars necessary for biopharmaceutical product and portfolio strategies. The medical team provides a deep understanding of the disease pathways and opportunities to intercept the disease. It is the single function that can truly place the patient at the center of a clinical and commercial strategy and provide a bridge between the two. If a differentiated, integrated and goal-oriented evidence-generation plan is to be designed and maintained, then setting a clear medical strategic direction for an asset must occur upstream. Providing medical and scientific context to the overall design and management of the portfolio is also critical and requires the medical team to play a lead role.
Through our laser-like focus on biopharma product and portfolio strategies, Prescient differentiates by bringing expertise, experience and evidence together to help you co-create winning strategies. Our team combines scientific expertise with commercial savviness and biopharma experience with core consultancy skills.
Integrating corporate, product and therapy area strategies is critical to provide a clear strategic direction that bridges science and commerce, ensuring the values of portfolios and brands are maximized. Creating a long-term and integrated vision of the therapeutic area requires effective upstream cross-functional collaboration between the R&D, medical and commercial teams.
No matter where they are in the drug development and commercialization journey, Prescient is by our clients’ sides. From early development to launch, from the critical first 12 months on the market to loss of exclusivity, we provide the dynamic insight, expertise, objectivity and creativity our clients need to make aligned decisions, differentiated decisions, valuable decisions.